InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,893.60
(
0.00%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.38
(
-0.05%
)
Bitcoin
57,493.90
(
1.39%
)
Post# of 252525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Thursday, 01/04/2007 1:20:04 PM

Thursday, January 04, 2007 1:20:04 PM

Post# of 252525
RPRX

The presentation for the phase II/III in UF couldn't be better. Very, very positive. The endometrial thickness results were spectacular--less thickening among Proellex patients at both doses than with placebo.

Presenter (a doc that treats UF, not an investigator or an RPRX employee) said that the results for UF symptom survey were "highly clinically significant."
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up